Presenting Author: Naomi Cruz (she/her/hers) – Rutgers School of Public Health
### she/her/hers @@@ Hillary Samples – Center for Pharmacoepidemiology and Treatment Science, Rutgers University ### 2325133###Co-Author######Center for Pharmacoepidemiology and Treatment Science, Rutgers University###Co-Author: Hillary Samples – Center for Pharmacoepidemiology and Treatment Science, Rutgers University
### @@@ Stephen Crystal, Ph.D. – Center for Health Services Research, Rutgers University ### 1358692###Co-Author###Board of Governors Professor###Center for Health Services Research, Rutgers University###Co-Author: Stephen Crystal, Ph.D. – Center for Health Services Research, Rutgers University
### @@@ Fangzhou Xie – Rutgers University ### 2325134###Co-Author######Rutgers University###Co-Author: Fangzhou Xie – Rutgers University
### @@@ Mark Olfson – New York State Psychiatric Institute, Columbia University ### 1358690###Co-Author######New York State Psychiatric Institute, Columbia University###Co-Author: Mark Olfson – New York State Psychiatric Institute, Columbia University
### @@@ Greta A. Bushnell, PhD, MSPH – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ, USA ### 1358831###Co-Author###Assistant Professor###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ, USA###Co-Author: Greta A. Bushnell, PhD, MSPH – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ, USA
###Presenting Author: Dena H. Jaffe, MSc PhD (she/her/hers) – Oracle Health
### she/her/hers @@@ Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts ### 1093509###Co-Author###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts###Co-Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
### @@@ Elise Berliner – Oracle ### 2364852###Co-Author######Oracle###Co-Author: Elise Berliner – Oracle
### @@@ Sarah K. Dutcher, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 2326839###Co-Author###Lead Epidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: Sarah K. Dutcher, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
###Moderator: Oluwadamilola Onasanya, MD, MPH, PhD Candidate – University of Maryland, Baltimore/Carelon Research
### @@@ Blanaid Hicks, PhD – Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland ### 1093536###Moderator###Senior Lecturer###Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland###Moderator: Blanaid Hicks, PhD – Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland
###Lead Speaker: Nancy A. Dreyer, PhD, MPH, FISPE, Fellow DIA (she/her/hers) – Dreyer Strategies LLC
### she/her/hers @@@ Mackenzie Herzog, PhD, MPH – IQVIA ### 2330847###Speaker###Director, Epidemiology###IQVIA###Speaker: Mackenzie Herzog, PhD, MPH – IQVIA
### @@@ William G. Dixon, MD PhD – University of Manchester ### 1062521###Speaker###Professor of Digital Epidemiology###University of Manchester###Speaker: William G. Dixon, MD PhD – University of Manchester
### @@@ Kristen A. Hahn, MPH, PhD (she/her/hers) – PicnicHealth ### 1721252###Speaker###Head of RWE Research###PicnicHealth###Speaker: Kristen A. Hahn, MPH, PhD (she/her/hers) – PicnicHealth
### she/her/hersLead Speaker: Timothy Savage, MD, MPH, MSc (he/him/his) – Brigham and Women's Hospital
### he/him/his @@@ Julien E. Heidt, MS – IQVIA ### 2325212###Speaker###Senior Consultant Epidemiologist, Regulatory Science and Study Innovation###IQVIA###Speaker: Julien E. Heidt, MS – IQVIA
### @@@ Jie J. Li, PhD (she/her/hers) – Office of Surveillance and Epidemiology, CDER, US FDA ### 1062564###Speaker###Associate Director RWE###Office of Surveillance and Epidemiology, CDER, US FDA###Speaker: Jie J. Li, PhD (she/her/hers) – Office of Surveillance and Epidemiology, CDER, US FDA
### she/her/hers @@@ Daniel Rosenberg, PhD – Johnson & Johnson ### 1993532###Speaker###Cross-Therapy Area Leader, Global Epidemiology###Johnson & Johnson###Speaker: Daniel Rosenberg, PhD – Johnson & Johnson
### @@@ Tara MacCannell, PhD MSc – Vertex Pharmaceuticals ### 2325213###Speaker###Global Head of RWE, Executive Director###Vertex Pharmaceuticals###Speaker: Tara MacCannell, PhD MSc – Vertex Pharmaceuticals
### @@@ Delphine Saragoussi, MD, MScPH – Evidera, a business unit of PPD, part of Thermo Fisher Scientific ### 1359687###Speaker###Executive DIrector Epidemiology and Scientific Affairs###Evidera, a business unit of PPD, part of Thermo Fisher Scientific###Speaker: Delphine Saragoussi, MD, MScPH – Evidera, a business unit of PPD, part of Thermo Fisher Scientific
###